psychopharmacology

Latest

psychopharmacology

·November 18, 2022·5 min read

Can Pharmacotherapies Prevent Alcohol Use Disorder in People With PTSD?

Those with PTSD are almost twice as likely to develop alcohol use disorder than their peers who have not experienced trauma. Researchers report drugs that block FKBP5, such as benztropine, a drug used to control symptoms of Parkinson's disease, and the experimental compound SAFit2 reduce alcohol preference and drinking in models of PTSD.

This shows Vyvanse (Lisdexamfetamine) 70mg capsules

Featured Neuroscience Psychology

·November 17, 2022·5 min read

ADHD Medication for Amphetamine Addiction Linked to Reduced Risk of Hospitalization and Death

Lisdexamfetamine (Vyvanse), a medication commonly used to treat ADHD, lowers the risk of hospitalization and death for those with amphetamine use disorder.

Featured Neuroscience Open Neuroscience Articles

·November 16, 2022·4 min read

Is Ayahuasca Safe? New Study Tallies Adverse Events

Used to help treat mental health conditions, and improve spirituality, the plant-based psychoactive ayahuasca is becoming more popular. Researchers say there is a high rate of adverse physical and psychological effects from using ayahuasca although they are not generally severe.

This shows a depressed looking woman looking out a window

Featured Neuroscience Psychology

·November 15, 2022·4 min read

Potential New Lead Compounds for the Treatment of Depression and Anxiety Disorders

Study identifies potential new drugs that can help treat depression and anxiety disorders without many of the adverse effects of other medications currently under evaluation.

Featured Neuroscience Psychology

·November 15, 2022·11 min read

How Do SSRIs Like Prozac, Lexapro Really Work? Ask a Fruit Fly

Researchers shed light on how different SSRI antidepressants may work to help fight symptoms of depression in the brain.

Featured Neuroscience Psychology

·November 14, 2022·4 min read

Exposing Brain Tissue to Psilocybin Provides Insights Into Consciousness, Depression and Anxiety

Investigating how psychedelics such as psilocybin act on serotonin receptors, researchers shed new light on how the drugs affect consciousness and assist in treating a range of mental health disorders.

This shows the outline of a woman's head

Featured Neuroscience Psychology

·November 14, 2022·4 min read

Fentanyl Vaccine Potential ‘Game Changer’ for Opioid Epidemic

A newly developed vaccine blocks the ability of the opioid Fentanyl's ability to enter the brain, thus blocking the drug's "high".

Featured Neuroscience Psychology

·November 11, 2022·4 min read

Researchers Pinpoint ‘Depressing’ Gut Microbe With Potential for Psychobiotic Drugs

Examining the gut microbiome of those with major depressive disorder, researchers identify the presence of the bacteria Faecalibacterium prausnitzii as being responsible for the functional discrepancies between healthy individuals and those with MDD.

Featured Neuroscience Psychology

·November 9, 2022·7 min read

Mindfulness-Based Stress Reduction Is as Effective as an Antidepressant Drug for Treating Anxiety Disorders

Study reveals mindfulness-based stress reduction methods proved to be as effective as antidepressants for relieving symptoms for those with anxiety disorders.

This shows a sad woman sitting on a beach

Featured Neuroscience Psychology

·November 5, 2022·4 min read

Premenstrual Dysphoric Disorder: Examining the Psychological Symptoms

Premenstrual dysphoric disorder (PMDD) is a severe mood disorder that affects one in twenty women. PMDD can have a debilitating impact on the lives of sufferers. Researchers investigate PMDD and evaluate treatment options for sufferers.